Advertisement

Index by author

March 01, 2004; Volume 56,Issue 1

B

  1. Brink, Charles

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

C

  1. Catania, Anna

    1. Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1

  2. Colombo, Gualtiero

    1. Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1

  3. Commandeur, Jan N. M.

    1. Enzyme-Catalyzed Activation of Anticancer Prodrugs
      Martijn Rooseboom, Jan N. M. Commandeur and Nico P. E. Vermeulen
      Pharmacological Reviews March 2004, 56 (1) 53-102; DOI: https://doi.org/10.1124/pr.56.1.3

  4. Costa, Lucio G.

    1. Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
      Lucio G. Costa, Luca Steardo and Vincenzo Cuomo
      Pharmacological Reviews March 2004, 56 (1) 103-147; DOI: https://doi.org/10.1124/pr.56.1.5

  5. Cuomo, Vincenzo

    1. Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
      Lucio G. Costa, Luca Steardo and Vincenzo Cuomo
      Pharmacological Reviews March 2004, 56 (1) 103-147; DOI: https://doi.org/10.1124/pr.56.1.5

D

  1. Dahlén, Sven-Erik

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

  2. Drazen, Jeffrey

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

E

  1. Evans, Jilly F.

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

G

  1. Gatti, Stefano

    1. Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1

H

  1. Hay, Douglas W. P.

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

I

  1. Insel, Paul A.

    1. Autonomic Nervous System Pharmacogenomics: A Progress Report
      Shelli L. Kirstein and Paul A. Insel
      Pharmacological Reviews March 2004, 56 (1) 31-52; DOI: https://doi.org/10.1124/pr.56.1.2

K

  1. Kirstein, Shelli L.

    1. Autonomic Nervous System Pharmacogenomics: A Progress Report
      Shelli L. Kirstein and Paul A. Insel
      Pharmacological Reviews March 2004, 56 (1) 31-52; DOI: https://doi.org/10.1124/pr.56.1.2

L

  1. Lipton, James M.

    1. Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation
      Anna Catania, Stefano Gatti, Gualtiero Colombo and James M. Lipton
      Pharmacological Reviews March 2004, 56 (1) 1-29; DOI: https://doi.org/10.1124/pr.56.1.1

R

  1. Rooseboom, Martijn

    1. Enzyme-Catalyzed Activation of Anticancer Prodrugs
      Martijn Rooseboom, Jan N. M. Commandeur and Nico P. E. Vermeulen
      Pharmacological Reviews March 2004, 56 (1) 53-102; DOI: https://doi.org/10.1124/pr.56.1.3

  2. Rovati, G. Enrico

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

S

  1. Serhan, Charles N.

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

  2. Shimizu, Takao

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4

  3. Steardo, Luca

    1. Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects
      Lucio G. Costa, Luca Steardo and Vincenzo Cuomo
      Pharmacological Reviews March 2004, 56 (1) 103-147; DOI: https://doi.org/10.1124/pr.56.1.5

V

  1. Vermeulen, Nico P. E.

    1. Enzyme-Catalyzed Activation of Anticancer Prodrugs
      Martijn Rooseboom, Jan N. M. Commandeur and Nico P. E. Vermeulen
      Pharmacological Reviews March 2004, 56 (1) 53-102; DOI: https://doi.org/10.1124/pr.56.1.3

Y

  1. Yokomizo, Takehiko

    1. International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
      Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, G. Enrico Rovati, Charles N. Serhan, Takao Shimizu and Takehiko Yokomizo
      Pharmacological Reviews March 2004, 56 (1) 149-157; DOI: https://doi.org/10.1124/pr.56.1.4
Back to top

In this issue